A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
1 other identifier
observational
4,306
1 country
1
Brief Summary
"Chang Gung ECG Abnormality Detection Software" is a is an artificial intelligence medical signal analysis software that detect whether patients have abnormal ECG signals of 14 diseases by static 12-lead ECG. The 14 diseases were
- Long QT syndrome
- Sinus bradycardia
- Sinus Tachycardia
- Premature atrial complexes
- Premature ventricular complexes
- Atrial Flutter, Right bundle branch block
- Left bundle branch block
- Left Ventricular hypertrophy
- Anterior wall Myocardial Infarction
- Septal wall Myocardial Infarction
- Lateral wall Myocardial Infarction
- Inferior wall Myocardial Infarction
- Posterior wall Myocardial Infarction The main purpose of this study is to verify whether "Chang Gung ECG Abnormality Detection Software" can correctly identify abnormal ECG signals among patients of 14 diseases. The interpretation standard is the consensus of 3 cardiologists. The results of the software analysis will be used to evaluate the performance of the primary and secondary evaluation indicators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2023
CompletedFirst Posted
Study publicly available on registry
June 15, 2023
CompletedStudy Start
First participant enrolled
October 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedJanuary 11, 2024
May 1, 2023
4 months
June 6, 2023
January 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity and Specificity
The rate of test results that correctly indicate the presence and absence.
baseline
Secondary Outcomes (1)
Area Under the receiver operating characteristic Curve
Baseline
Study Arms (1)
Software diagnosis
Software diagnosis with gold standard of 3 cardiologists' interpretation.
Interventions
This device is expected to be used for the static 12-lead ECG to detect whether there are abnormal ECG signals related to diseases and outputs the results.
Eligibility Criteria
This is a retrospective study, and the data comes from the Chang Gung Medical Research Database(CGRD) which was an database form 6 hospitals of Chang Gung Memorial hospital. According to inclusion and exclusion criteria, de-identified static 12-lead ECG data from the database during 2006.01.01\~2019.12.31 was collected, and the length of the ECG was 10 seconds.
You may qualify if:
- Equal or greater than twenty years old.
- Static 12-lead electrocardiogram of General Electric MUSE XML format file.
- The data comes from the static 12-lead electrocardiogram device of General Electric (model MAC5500).
- The electrocardiogram signal is 500 Hz.
- The Alternating current (AC) filter of the electrocardiogram signal is 60 Hz.
- The resource of original diagnosis was a cardiologist.
You may not qualify if:
- Cases used in the model development process.
- Lacks any electrode.
- Contain any electrode lacks a segment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung memorial hospital
Taoyuan, 333, Taiwan
Related Publications (8)
Malik J, Devecioglu OC, Kiranyaz S, Ince T, Gabbouj M. Real-Time Patient-Specific ECG Classification by 1D Self-Operational Neural Networks. IEEE Trans Biomed Eng. 2022 May;69(5):1788-1801. doi: 10.1109/TBME.2021.3135622. Epub 2022 Apr 21.
PMID: 34910628BACKGROUNDAcharya U.R., Fujita H., Lih O.S., Adam M., Tan J.H., Chua C.K. Automated detection of coronary artery disease using different durations of ECG segments with convolutional neu-ral network Knowl.-Based Syst., 132 (sep.15) (2017), pp. 62-71
BACKGROUNDBos JM, Attia ZI, Albert DE, Noseworthy PA, Friedman PA, Ackerman MJ. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram. JAMA Cardiol. 2021 May 1;6(5):532-538. doi: 10.1001/jamacardio.2020.7422.
PMID: 33566059BACKGROUNDRibeiro AH, Ribeiro MH, Paixao GMM, Oliveira DM, Gomes PR, Canazart JA, Ferreira MPS, Andersson CR, Macfarlane PW, Meira W Jr, Schon TB, Ribeiro ALP. Automatic diagnosis of the 12-lead ECG using a deep neural network. Nat Commun. 2020 Apr 9;11(1):1760. doi: 10.1038/s41467-020-15432-4.
PMID: 32273514BACKGROUNDU. Rajendra Acharya, Hamido Fujita, Oh Shu Lih, Yuki Hagiwara, Jen Hong Tan, Muhammad Adam, Automated detection of arrhythmias using different intervals of tachycardia ECG seg-ments with convolutional neural network, Information Sciences, Volume 405, 2017, Pages 81-90, ISSN 0020-0255
BACKGROUNDJeong DU, Lim KM. Convolutional neural network for classification of eight types of arrhythmia using 2D time-frequency feature map from standard 12-lead electrocardiogram. Sci Rep. 2021 Oct 14;11(1):20396. doi: 10.1038/s41598-021-99975-6.
PMID: 34650175BACKGROUNDKwon JM, Jeon KH, Kim HM, Kim MJ, Lim SM, Kim KH, Song PS, Park J, Choi RK, Oh BH. Comparing the performance of artificial intelligence and conventional diagnosis criteria for detecting left ventricular hypertrophy using electrocardiography. Europace. 2020 Mar 1;22(3):412-419. doi: 10.1093/europace/euz324.
PMID: 31800031BACKGROUNDMakimoto H, Hockmann M, Lin T, Glockner D, Gerguri S, Clasen L, Schmidt J, Assadi-Schmidt A, Bejinariu A, Muller P, Angendohr S, Babady M, Brinkmeyer C, Makimoto A, Kelm M. Performance of a convolutional neural network derived from an ECG database in recognizing myocardial infarction. Sci Rep. 2020 May 21;10(1):8445. doi: 10.1038/s41598-020-65105-x.
PMID: 32439873BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chang-Fu Kuo, MD/Ph.D
Associate Professor and Director Division of Rheumatology
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2023
First Posted
June 15, 2023
Study Start
October 6, 2023
Primary Completion
January 31, 2024
Study Completion
February 28, 2024
Last Updated
January 11, 2024
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share